REFERENCES
1. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204-22.
2. Xu R, Li S, Li S, et al. Residential surrounding greenness and DNA methylation: an epigenome-wide association study. Environ Int. 2021;154:106556.
3. Zhang W, Song M, Qu J, Liu GH. Epigenetic modifications in cardiovascular aging and diseases. Circ Res. 2018;123:773-86.
4. Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary behavior, exercise, and cardiovascular health. Circ Res. 2019;124:799-815.
5. Teo KK, Ounpuu S, Hawken S, et al.; INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368:647-58.
6. Carbone S, Del Buono MG, Ozemek C, Lavie CJ. Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness. Prog Cardiovasc Dis. 2019;62:327-33.
7. Zhao B, Meng Y, Jin X, et al. Association of objective and self-reported sleep duration with all-cause and cardiovascular disease mortality: a community-based study. J Am Heart Assoc. 2023;12:e027832.
8. Kaminsky LA, German C, Imboden M, Ozemek C, Peterman JE, Brubaker PH. The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease. Prog Cardiovasc Dis. 2022;70:8-15.
9. Mehta A, Kondamudi N, Laukkanen JA, et al. Running away from cardiovascular disease at the right speed: the impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular disease risk and associated subclinical phenotypes. Prog Cardiovasc Dis. 2020;63:762-74.
10. Miller V, Mente A, Dehghan M, et al.; Prospective Urban Rural Epidemiology (PURE) study investigators. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet. 2017;390:2037-49.
11. Dunstan DW, Dogra S, Carter SE, Owen N. Sit less and move more for cardiovascular health: emerging insights and opportunities. Nat Rev Cardiol. 2021;18:637-48.
12. Bellettiere J, LaMonte MJ, Evenson KR, et al. Sedentary behavior and cardiovascular disease in older women: the OPACH study. Circulation. 2019;139:1036-46.
13. Boursiquot BC, Bellettiere J, LaMonte MJ, LaCroix AZ, Perez MV. Sedentary behavior and atrial fibrillation in older women: the OPACH study. J Am Heart Assoc. 2022;11:e023833.
14. LaMonte MJ, LaCroix AZ, Nguyen S, et al. Accelerometer-measured physical activity, sedentary time, and heart failure risk in women aged 63 to 99 years. JAMA Cardiol. 2024;9:336-45.
15. Abdel-Sater KA. The role of anti-aging approaches in managing hypogonadism in sedentary older males. Front Aging. 2024;5:1514438.
16. Chen CCW, Erlich AT, Crilly MJ, Hood DA. Parkin is required for exercise-induced mitophagy in muscle: impact of aging. Am J Physiol Endocrinol Metab. 2018;315:E404-15.
17. Moreno-Agostino D, Daskalopoulou C, Wu YT, et al. The impact of physical activity on healthy ageing trajectories: evidence from eight cohort studies. Int J Behav Nutr Phys Act. 2020;17:92.
18. Fujimoto N, Prasad A, Hastings JL, et al. Cardiovascular effects of 1 year of progressive and vigorous exercise training in previously sedentary individuals older than 65 years of age. Circulation. 2010;122:1797-805.
19. Grace F, Herbert P, Elliott AD, Richards J, Beaumont A, Sculthorpe NF. High intensity interval training (HIIT) improves resting blood pressure, metabolic (MET) capacity and heart rate reserve without compromising cardiac function in sedentary aging men. Exp Gerontol. 2018;109:75-81.
20. Yang Y, Wang Y, Yang L. Association between physical activity and sedentary behavior and depression in US adults with cardiovascular disease: NHANES 2007-2016. J Affect Disord. 2024;367:342-9.
21. Ahmadi MN, Rezende LFM, Ferrari G, Del Pozo Cruz B, Lee IM, Stamatakis E. Do the associations of daily steps with mortality and incident cardiovascular disease differ by sedentary time levels? A device-based cohort study. Br J Sports Med. 2024;58:261-8.
22. Ji H, Gulati M, Huang TY, et al. Sex differences in association of physical activity with all-cause and cardiovascular mortality. J Am Coll Cardiol. 2024;83:783-93.
23. Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Investig. 2017;47:600-11.
24. Villar-Fincheira P, Sanhueza-Olivares F, Norambuena-Soto I, et al. Role of interleukin-6 in vascular health and disease. Front Mol Biosci. 2021;8:641734.
25. Roberts LM, Jaeger BC, Baptista LC, et al. Wearable technology to reduce sedentary behavior and CVD risk in older adults: a pilot randomized clinical trial. Clin Interv Aging. 2019;14:1817-28.
26. Al-Kindi SG, Brook RD, Biswal S, Rajagopalan S. Environmental determinants of cardiovascular disease: lessons learned from air pollution. Nat Rev Cardiol. 2020;17:656-72.
27. Brook RD, Rajagopalan S, Pope CA 3rd, et al.; American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-78.
28. Brauer M, Casadei B, Harrington RA, Kovacs R, Sliwa K.; WHF Air Pollution Expert Group. Taking a stand against air pollution - the impact on cardiovascular disease: a joint opinion from the world heart federation, american college of cardiology, american heart association, and the european society of cardiology. Eur Heart J. 2021;42:1460-3.
29. Nice KA, Thompson J, Zhao H, et al. Effects of city design on transport mode choice and exposure to health risks during and after a crisis: a retrospective observational analysis. Lancet Planet Health. 2025;9:e467-79.
30. Chen H, Burnett RT, Bai L, et al. Residential greenness and cardiovascular disease incidence, readmission, and mortality. Environ Health Perspect. 2020;128:87005.
31. Zhang K, Brook RD, Li Y, Rajagopalan S, Kim JB. Air pollution, built environment, and early cardiovascular disease. Circ Res. 2023;132:1707-24.
32. Wang Y, Wellenius GA, Hickson DA, Gjelsvik A, Eaton CB, Wyatt SB. Residential proximity to traffic-related pollution and atherosclerosis in 4 vascular beds among African-American adults: results from the Jackson heart study. Am J Epidemiol. 2016;184:732-43.
33. Eze IC, Jeong A, Schaffner E, et al. Genome-wide DNA methylation in peripheral blood and long-term exposure to source-specific transportation noise and air pollution: the SAPALDIA study. Environ Health Perspect. 2020;128:67003.
34. Niedhammer I, Bertrais S, Witt K. Psychosocial work exposures and health outcomes: a meta-review of 72 literature reviews with meta-analysis. Scand J Work Environ Health. 2021;47:489-508.
35. Potter EL, Hopper I, Sen J, Salim A, Marwick TH. Impact of socioeconomic status on incident heart failure and left ventricular dysfunction: systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes. 2019;5:169-79.
36. Li J, Ji F, Song J, et al. Anxiety and clinical outcomes of patients with acute coronary syndrome: a meta-analysis. BMJ Open. 2020;10:e034135.
37. Cao H, Zhao H, Shen L. Depression increased risk of coronary heart disease: a meta-analysis of prospective cohort studies. Front Cardiovasc Med. 2022;9:913888.
38. Wang Y, Huang B, Sun M, Yu B, Lin P. Type D personality as a risk factor for 3-year cardiovascular events in patients with coronary artery disease and their spouse: a prospective cohort study. Eur J Prev Cardiol. 2025;32:430-40.
39. Wirtz PH, von Känel R. Psychological stress, inflammation, and coronary heart disease. Curr Cardiol Rep. 2017;19:111.
40. Konstantinou E, Fotopoulou F, Drosos A, et al. Tobacco-specific nitrosamines: a literature review. Food Chem Toxicol. 2018;118:198-203.
41. Kim KH, Jahan SA, Kabir E, Brown RJ. A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects. Environ Int. 2013;60:71-80.
42. Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler, Thromb, Vasc Biol. 2014;34:509-15.
43. El-Mahdy MA, Abdelghany TM, Hemann C, et al. Chronic cigarette smoke exposure triggers a vicious cycle of leukocyte and endothelial-mediated oxidant stress that results in vascular dysfunction. Am J Physiol Heart Circ Physiol. 2020;319:H51-65.
44. Hu N, Yang L, Dong M, Ren J, Zhang Y. Deficiency in adiponectin exaggerates cigarette smoking exposure-induced cardiac contractile dysfunction: role of autophagy. Pharmacol Res. 2015;100:175-89.
45. Qasim H, Alarabi AB, Alzoubi KH, Karim ZA, Alshbool FZ, Khasawneh FT. The effects of hookah/waterpipe smoking on general health and the cardiovascular system. Environ Health Prev Med. 2019;24:58.
46. Bhatnagar A, Maziak W, Eissenberg T, et al. Water pipe (hookah) smoking and cardiovascular disease risk: a scientific statement from the American Heart Association. Circulation. 2019;139:e917-36.
47. Alomari MA, Al-Sheyab NA, Khabour OF, Alzoubi KH. Serum VEGF level is different in adolescents smoking waterpipe versus cigarettes: the irbid TRY. Biomolecules. 2018;8:102.
48. Alomari MA, Khabour OF, Alzoubi KH, Shqair DM, Stoner L. Acute vascular effects of waterpipe smoking: importance of physical activity and fitness status. Atherosclerosis. 2015;240:472-6.
49. El-Mahdy MA, Ewees MG, Eid MS, Mahgoup EM, Khaleel SA, Zweier JL. Electronic cigarette exposure causes vascular endothelial dysfunction due to NADPH oxidase activation and eNOS uncoupling. Am J Physiol Heart Circ Physiol. 2022;322:H549-67.
50. Kuntic M, Oelze M, Steven S, et al. Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase (NOX-2). Eur Heart J. 2020;41:2472-83.
51. Derella CC, Tingen MS, Blanks A, et al. Smoking cessation reduces systemic inflammation and circulating endothelin-1. Sci Rep. 2021;11:24122.
52. Wang M, Li Y, Lai M, et al. Alcohol consumption and epigenetic age acceleration across human adulthood. Aging. 2023;15:10938-71.
53. Fernández-Solà J. The effects of ethanol on the heart: alcoholic cardiomyopathy. Nutrients. 2020;12:572.
54. Del Giorno R, Maddalena A, Bassetti S, Gabutti L. Association between alcohol intake and arterial stiffness in healthy adults: a systematic review. Nutrients. 2022;14:1207.
55. Mukhopadhyay P, Yokus B, Paes-Leme B, et al. Chronic alcohol consumption accelerates cardiovascular aging and decreases cardiovascular reserve capacity. Geroscience. 2025;47:5881-901.
56. Piacenza L, Zeida A, Trujillo M, Radi R. The superoxide radical switch in the biology of nitric oxide and peroxynitrite. Physiol Rev. 2022;102:1881-906.
57. Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123:849-67.
58. Al Attar AA, Fahed GI, Hoballah MM, et al. Mechanisms underlying the effects of caloric restriction on hypertension. Biochem Pharmacol. 2022;200:115035.
59. Csiszar A, Gautam T, Sosnowska D, et al. Caloric restriction confers persistent anti-oxidative, pro-angiogenic, and anti-inflammatory effects and promotes anti-aging miRNA expression profile in cerebromicrovascular endothelial cells of aged rats. Am J Physiol Heart Circ Physiol. 2014;307:H292-306.
60. Csiszar A, Sosnowska D, Tucsek Z, et al. Circulating factors induced by caloric restriction in the nonhuman primate Macaca mulatta activate angiogenic processes in endothelial cells. J Gerontol A Biol Sci Med Sci. 2013;68:235-49.
61. Trichopoulou A, Martínez-González MA, Tong TY, et al. Definitions and potential health benefits of the Mediterranean diet: views from experts around the world. BMC Med. 2014;12:112.
62. GómezSánchez M, Gómez Sánchez L, Patino-Alonso MC, et al. Adherence to the mediterranean diet in Spanish population and its relationship with early vascular aging according to sex and age: EVA study. Nutrients. 2020;12:1205.
63. Li J, Capuano AW, Agarwal P, et al. The MIND diet, brain transcriptomic alterations, and dementia. Alzheimers Dement. 2024;20:5996-6007.
64. Akbar Z, Fituri S, Ouagueni A, et al. Associations of the MIND diet with cardiometabolic diseases and their risk factors: a systematic review. Diabetes Metab Syndr Obes. 2023;16:3353-71.
65. Ungvari Z, Kunutsor SK. Coffee consumption and cardiometabolic health: a comprehensive review of the evidence. Geroscience. 2024;46:6473-510.
66. Scioli MG, Storti G, D'Amico F, et al. Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets. J Clin Med. 2020;9:1995.
67. N Kolodkin A, Sharma RP, Colangelo AM, et al. ROS networks: designs, aging, Parkinson’s disease and precision therapies. NPJ Syst Biol Appl. 2020;6:34.
68. Wang Y, Li Y, He C, Gou B, Song M. Mitochondrial regulation of cardiac aging. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1853-64.
69. Schmidlin CJ, Dodson MB, Madhavan L, Zhang DD. Redox regulation by NRF2 in aging and disease. Free Radical Biol Med. 2019;134:702-7.
70. Dato S, Crocco P, D'Aquila P, et al. Exploring the role of genetic variability and lifestyle in oxidative stress response for healthy aging and longevity. Int J Mol Sci. 2013;14:16443-72.
71. Frasca D, Blomberg BB. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. 2016;17:7-19.
72. McKechnie DGJ, Papacosta AO, Lennon LT, Ramsay SE, Whincup PH, Wannamethee SG. Associations between inflammation, cardiovascular biomarkers and incident frailty: the British Regional Heart Study. Age Ageing. 2021;50:1979-87.
73. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505-22.
74. Youm YH, Grant RW, McCabe LR, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013;18:519-32.
76. Ramji DP, Davies TS. Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev. 2015;26:673-85.
77. Feng YS, Tan ZX, Wu LY, Dong F, Zhang F. The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease. Ageing Res Rev. 2020;64:101192.
78. Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol. 2018;9:586.
79. Evans AK, Saw NL, Woods CE, et al. Impact of high-fat diet on cognitive behavior and central and systemic inflammation with aging and sex differences in mice. Brain Behav Immun. 2024;118:334-54.
80. Dioum EHM, Schneider KL, Vigerust DJ, et al. Oats lower age-related systemic chronic inflammation (iAge) in adults at risk for cardiovascular disease. Nutrients. 2022;14:4471.
81. Estruch R, Ros E, Martínez-González MA. Mediterranean diet for primary prevention of cardiovascular disease. N Engl J Med. 2013;369:676-7.
82. Hamer M, Lavoie KL, Bacon SL. Taking up physical activity in later life and healthy ageing: the English longitudinal study of ageing. Br J Sports Med. 2014;48:239-43.
83. Mahmud F, Sarker DB, Jocelyn JA, Sang QA. Molecular and cellular effects of microplastics and nanoplastics: focus on inflammation and senescence. Cells. 2024;13:1788.
84. Li H, Xia N. The role of oxidative stress in cardiovascular disease caused by social isolation and loneliness. Redox Biol. 2020;37:101585.
85. Xia N, Li H. Loneliness, social isolation, and cardiovascular health. Antioxid Redox Signaling. 2018;28:837-51.
86. Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and mitophagy in cardiovascular disease. Circ Res. 2017;120:1812-24.
87. Nguyen TN, Padman BS, Lazarou M. Deciphering the molecular signals of PINK1/Parkin mitophagy. Trends Cell Biol. 2016;26:733-44.
88. Marinković M, Šprung M, Novak I. Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery. Autophagy. 2021;17:1232-43.
89. Zhang W, Siraj S, Zhang R, Chen Q. Mitophagy receptor FUNDC1 regulates mitochondrial homeostasis and protects the heart from I/R injury. Autophagy. 2017;13:1080-1.
91. Wu N, Zheng W, Zhou Y, et al. Autophagy in aging-related diseases and cancer: principles, regulatory mechanisms and therapeutic potential. Ageing Res Rev. 2024;100:102428.
92. Montégut L, Joseph A, Chen H, et al. DBI/ACBP is a targetable autophagy checkpoint involved in aging and cardiovascular disease. Autophagy. 2023;19:2166-9.
93. Sciarretta S, Yee D, Nagarajan N, et al. Trehalose-induced activation of autophagy improves cardiac remodeling after myocardial infarction. J Am Coll Cardiol. 2018;71:1999-2010.
94. Eisenberg T, Abdellatif M, Schroeder S, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. 2016;22:1428-38.
95. D'Amico A, Fossati C, Pigozzi F, et al. Natural activators of autophagy reduce oxidative stress and muscle injury biomarkers in endurance athletes: a pilot study. Nutrients. 2023;15-459.
96. Kiechl S, Pechlaner R, Willeit P, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. Am J Clin Nutr. 2018;108:371-80.
97. Hofer SJ, Simon AK, Bergmann M, Eisenberg T, Kroemer G, Madeo F. Mechanisms of spermidine-induced autophagy and geroprotection. Nat Aging. 2022;2:1112-29.
98. Hofer SJ, Daskalaki I, Bergmann M, et al. Spermidine is essential for fasting-mediated autophagy and longevity. Nat Cell Biol. 2024;26:1571-84.
99. Ramos ELP, Sousa Neto IV, Pinto AP, et al. Mechanisms underlying the interplay between autophagy and the inflammasome in age-related diseases: implications for exercise immunology. Ageing Res Rev. 2025;110:102821.
100. Hassink RJ, Pasumarthi KB, Nakajima H, et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res. 2008;78:18-25.
101. Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev. 2019;99:1765-817.
102. Marian AJ. Causes and consequences of DNA double-stranded breaks in cardiovascular disease. Mol Cell Biochem. 2025;480:2043-64.
103. Lozhkin A, Vendrov AE, Ramos-Mondragón R, et al. Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics. Redox Biol. 2022;57:102474.
104. Mir SM, Samavarchi Tehrani S, Goodarzi G, et al. Shelterin complex at telomeres: implications in ageing. Clin Interv Aging. 2020;15:827-39.
105. Cai K, Jiang H, Zou Y, et al. Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches. Pharmacol Res. 2024;206:107281.
106. Kamo T, Akazawa H, Komuro I. Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circ Res. 2015;117:89-98.
107. Saucerman JJ, Tan PM, Buchholz KS, McCulloch AD, Omens JH. Mechanical regulation of gene expression in cardiac myocytes and fibroblasts. Nat Rev Cardiol. 2019;16:361-78.
108. Adao DMT, Ching C, Fish JE, Simmons CA, Billia F. Endothelial cell-cardiomyocyte cross-talk: understanding bidirectional paracrine signaling in cardiovascular homeostasis and disease. Clin Sci. 2024;138:1395-419.
109. Wang Q, Ismahil MA, Zhu Y, et al. CD206+IL-4Rα+ macrophages are drivers of adverse cardiac remodeling in ischemic cardiomyopathy. Circulation. 2025;152:257-73.
110. Ozcebe SG, Bahcecioglu G, Yue XS, Zorlutuna P. Effect of cellular and ECM aging on human iPSC-derived cardiomyocyte performance, maturity and senescence. Biomaterials. 2021;268:120554.
111. Ye Y, Yang K, Liu H, et al. SIRT2 counteracts primate cardiac aging via deacetylation of STAT3 that silences CDKN2B. Nat Aging. 2023;3:1269-87.
112. Okabe K, Yaku K, Uchida Y, et al. Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects. Front Nutr. 2022;9:868640.
113. Nie H, Zhang Y, Yu H, Xiao H, Li T, Yang Q. Oral delivery of carrier-free dual-drug nanocrystal self-assembled microspheres improved NAD+ bioavailability and attenuated cardiac ischemia/reperfusion injury in mice. Drug Delivery. 2021;28:433-44.
114. Hastings MH, Castro C, Freeman R, et al. Intrinsic and extrinsic contributors to the cardiac benefits of exercise. JACC Basic Transl Sci. 2024;9:535-52.
115. Monk BA, George SJ. The effect of ageing on vascular smooth muscle cell behaviour-a mini-review. Gerontology. 2015;61:416-26.
116. Akinmolayan A, Papacosta AO, Lennon LT, et al. Carotid intima-media thickness, carotid distensibility, and incident heart failure in older men: the British regional heart study. J Am Heart Assoc. 2025;14:e037167.
117. Toda N. Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther. 2012;133:159-76.
118. Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circ Res. 2023;132:1050-63.
120. Hwang HJ, Kim N, Herman AB, Gorospe M, Lee JS. Factors and pathways modulating endothelial cell senescence in vascular aging. Int J Mol Sci. 2022;23:10135.
121. Jia G, Aroor AR, Jia C, Sowers JR. Endothelial cell senescence in aging-related vascular dysfunction. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1802-9.
122. Donato AJ, Machin DR, Lesniewski LA. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ Res. 2018;123:825-48.
123. Nicoll R, Henein MY. The predictive value of arterial and valvular calcification for mortality and cardiovascular events. Int J Cardiol Heart Vessel. 2014;3:1-5.
124. Ceneri N, Zhao L, Young BD, et al. Rac2 modulates atherosclerotic calcification by regulating macrophage interleukin-1β production. Arterioscler, Thromb, Vasc Biol. 2017;37:328-40.
125. Van Campenhout A, Golledge J. Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis. 2009;204:321-9.
126. De Maré A, Opdebeeck B, Neven E, D'Haese PC, Verhulst A. Sclerostin protects against vascular calcification development in mice. J Bone Miner Res. 2022;37:687-99.
127. Climie RE, Alastruey J, Mayer CC, et al. Vascular ageing: moving from bench towards bedside. Eur J Prev Cardiol. 2023;30:1101-17.
128. Olive M, Harten I, Mitchell R, et al. Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. Arterioscler, Thromb, Vasc Biol. 2010;30:2301-9.
129. Gomez-Sanchez M, Gomez-Sanchez L, Patino-Alonso MC, et al.; EVA Investigators. Vascular aging and its relationship with lifestyles and other risk factors in the general Spanish population: early vascular ageing study. J Hypertens. 2020;38:1110-22.
130. Sugawara J, Tomoto T, Noda N, et al. Effects of endothelin-related gene polymorphisms and aerobic exercise habit on age-related arterial stiffening: a 10-yr longitudinal study. J Appl Physiol. 2018;124:312-20.
131. Grigorova YN, Wei W, Petrashevskaya N, et al. Dietary sodium restriction reduces arterial stiffness, vascular TGF-β-dependent fibrosis and marinobufagenin in young normotensive rats. Int J Mol Sci. 2018;19:3168.
132. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol. 2011;57:1511-22.
133. Herzog MJ, Müller P, Lechner K, et al. Arterial stiffness and vascular aging: mechanisms, prevention, and therapy. Signal Transduct Target Ther. 2025;10:282.
134. Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Annu Rev Physiol. 2011;73:29-46.
135. Massera D, Kizer JR, Dweck MR. Mechanisms of mitral annular calcification. Trends Cardiovasc Med. 2020;30:289-95.
136. Sengupta SP, Mohan JC. Calcific mitral stenosis: echoes of aging. J Am Coll Cardiol. 2020;75:3058-60.
137. Zoghbi WA, Levine RA, Flachskampf F, et al. Atrial functional mitral regurgitation: a JACC: cardiovascular imaging expert panel viewpoint. JACC Cardiovasc Imaging. 2022;15:1870-82.
138. Pio SM, Medvedofsky D, Delgado V, et al.; COAPT Trial Investigators. Left atrial improvement in patients with secondary mitral regurgitation and heart failure: the COAPT trial. JACC Cardiovasc Imaging. 2024;17:1015-27.
139. Forrester SJ, Booz GW, Sigmund CD, et al. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018;98:1627-738.
140. Ren LL, Miao H, Wang YN, Liu F, Li P, Zhao YY. TGF-β as a master regulator of aging-associated tissue fibrosis. Aging Dis. 2023;14:1633-50.
141. Smyrnias I, Gray SP, Okonko DO, et al. Cardioprotective effect of the mitochondrial unfolded protein response during chronic pressure overload. J Am Coll Cardiol. 2019;73:1795-806.
142. Rogers MA, Maldonado N, Hutcheson JD, et al. Dynamin-related protein 1 inhibition attenuates cardiovascular calcification in the presence of oxidative stress. Circ Res. 2017;121:220-33.
143. Kjeldsen EW, Thomassen JQ, Rasmussen KL, Nordestgaard BG, Tybjærg-Hansen A, Frikke-Schmidt R. Cardiovascular risk factors and aortic valve stenosis: towards 10-year absolute risk charts for primary prevention. Eur J Prev Cardiol. 2025;32:1684-93.
